glp-1 sex drive Clinical review of how glucagon-like peptide-1 agonist obesity medications decrease sexual desire, and a biopsychosocial model for why we don't 'see' it Exclusive | We lost weight

Some patients pursue TRICARE coverage first, then switch to compounded tirzepatide if denied

Some advanced protocols pair Tesamorelin with Ipamorelin or other peptides to sustain GH signaling and further support body composition, but these combinations should only be used under experienced medical supervision. Who should avoid Ipamorelin therapy

A common symptom is a feeling of fullness that lasts several hours after eating

Those results demonstrate that regulation of central metabolism is responsible for the observed robustness of cytosolic NADP redox status, which is itself a prerequisite for the previously-described robustness of the glutathione redox status

Parisi S (2025)